Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026)
Hims & Hers Health (HIMS) posted Change in Account Payables of $167.6 million for Q1 2026, up 466.02% sequentially from -$45.8 million in Q4 2025, and up 1058.32% YoY from $14.5 million in Q1 2025.
Hims & Hers Health (HIMS) Change in Account Payables (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Change in Account Payables for 8 years, with the latest figure at $167.6 million in Q1 2026.
- Quarterly Change in Account Payables rose 1058.32% year-over-year to $167.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $183.5 million (up 236.14% YoY) and the FY2025 annual result came in at $30.3 million, down 30.69% from the prior year.
- Change in Account Payables grew to $167.6 million in Q1 2026 per HIMS's latest filing, from -$45.8 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $167.6 million in Q1 2026 and troughed at -$45.8 million in Q4 2025.
- A 5-year average of $15.4 million and a median of $4.0 million in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2024 and 2025: Change in Account Payables soared 1922.18% in 2024, then sank 629.0% in 2025.
- Over 5 years, Change in Account Payables stood at -$609000.0 in 2022, then jumped by 579.97% to $2.9 million in 2023, then soared by 196.2% to $8.7 million in 2024, then tumbled by 629.0% to -$45.8 million in 2025, then surged by 466.02% to $167.6 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $167.6 million, -$45.8 million, and $71.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 156.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 156.15 Mn |
| Jun 30, 2026 | 156.15 Mn |
| Mar 31, 2026 | 167.64 Mn |
| Mar 31, 2026 | 167.64 Mn |
| Dec 31, 2025 | -45.80 Mn |
| Dec 31, 2025 | -45.80 Mn |
| Sep 30, 2025 | 70.95 Mn |
| Sep 30, 2025 | 70.95 Mn |
| Jun 30, 2025 | -9.33 Mn |
| Jun 30, 2025 | -9.33 Mn |
| Mar 31, 2025 | 14.47 Mn |
| Mar 31, 2025 | 14.47 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Mar 31, 2024 | 3.60 Mn |